Treatment Persistence With Combination Versus Monotherapy in Commercially Insured Patients With Rheumatoid Arthritis

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.03.296
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Combination Treatment Is Rare in Patients With Rheumatoid Arthritis

BMJ
1998English

Infliximab Treatment in Combination With Cyclosporin a in Patients With Severe Refractory Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2002English

Economic Evaluation of Tocilizumab Monotherapy vs Adalimumab Monotherapy in Patients With Rheumatoid Arthritis in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Persistence Rate With Subcutaneous Biologic Therapies in Patients With Rheumatoid Arthritis (Ra)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Cyclosporin a Monotherapy Versus Cyclosporin a and Methotrexate Combination Therapy in Patients With Early Rheumatoid Arthritis: A Double Blind Randomised Placebo Controlled Trial

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2003English

Persistence With Biologic Agents for the Treatment of Rheumatoid Arthritis in Japan

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2016English

Patients’ Views About Treatment With Combination Therapy for Rheumatoid Arthritis: A Comparative Qualitative Study

BMC Musculoskeletal Disorders
RheumatologyOrthopedicsSports Medicine
2012English

Efficacy of Tofacitinib Monotherapy in Methotrexate-Naive Patients With Early or Established Rheumatoid Arthritis

RMD Open
RheumatologyAllergyImmunology
2016English

Effect of Complex Periodontal Treatment in Patients With Rheumatoid Arthritis

Scientific and practical journal "Stomatological Bulletin"
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy